Dermatology diagnostic devices are the specialized medical devices which are utilized to diagnose various skin conditions from your skin. Dermatology is amongst the lucrative markets in the medical industry. Dermatology diagnostic devices are the best tools to use to diagnose various skin conditions in a faster and effective way. By using these devices, doctors can assess various skin conditions like acne, cellulite, wrinkles etc. and can recommend the right treatment for the particular skin problem. Dermatology devices also include laboratory instruments like spectrums, test panels and other diagnostic equipment. The Dermatology diagnostic devices market has been growing steadily over the years and there has been considerable rise in its demand. This has been possible because of rise in demand due to rising cases of skin related diseases like acne, eczema, skin wrinkles, etc. The growth also occurs as result of improved technology and introduction of new products in the market. According to a study by Clinical Dermatology, in 2013, approximately 25% of the population suffers from skin ailments globally, out of which 15% of the population consult general physician with skin problem, wherein 1.2% refer to the dermatologist while rest are left unattended. It has also been stated that skin conditions are the fourth leading cause of nonfatal disease burden.
Get Sample Report with Latest Covid19 Impact Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/933
Dermatology diagnostic devices and therapeutics market Taxonomy
By Product Type
- Dermatoscopes
- Contact Oil Immersion Dermatoscopes
- Hybrid Dermatoscopes
- Cross-Polarized Dermatoscopes
- Microscopes and Trichoscopes
- Multispectral Photoacaustic Microscope
- Raman Spectroscopy
- Reflectance Confocal Microscopy
- Imaging Equipment
- X-ray
- Ultrasound
- Magnetic Resonance Imaging
- Optical Coherence Tomography
By Drug Class
- Antibacterial Agents
- Antifungal Agents
- Antiviral Agents
- Corticosteroids
- Retinoids
- Immunosuppressants
- Biologics
Growing prevalence of skin disease is fuelling the market growth
High prevalence of skin problem such as fungal infections, scabies, acne, psoriasis, and atopic eczema is driving growth of the Dermatology diagnostic devices and therapeutic market. According to a study by Global Burden of Disease (GBD), in 2010, fungal skin disease, subcutaneous disease, and acne are ranked among the top ten most prevalent diseases worldwide. rise of pollutants in the environment, drug patent expiry, over use of cosmetics, prevalence of chronic diseases, and increasing pool of children affected with skin ailments are other major factor augmenting growth of the market. Growing awareness regarding skin ailments and its treatment is another major factor augmenting the dermatology diagnostic device and therapeutic market growth. New and improved dermatology diagnostics products, for instance, in 2016 Sun Pharmaceutical Industries Ltd launched Suncros, a highly efficient product for all skin ailments, contributed largely towards the market growth.
Get PDF Brochure with Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/933
Regional Insight of the dermatology diagnostic devices and therapeutics market
Geographically, 33.2 % population of North America have significant skin ailments that deserve medical attention. According to the Journal of the American Academy of Dermatology, around 50 million people were affected with acne in North America in 2010, out of which 85% aged between 12 and 24, accounting to higher ratio in young population. In 2017, Food and Drug Administration (FDA) has approved a new product named Dupixent, which is used to treat atopic dermatitis, expected to propel the market growth in this region. According to a report by European Dermato-Epidemiology, in 2014, approximately 19% of the adults and 14% of children have skin diseases that need to be attended in Europe. This is majorly due to high prevalence and awareness of skin ailments, well-organized healthcare services, and favorable reimbursement policies.
Recent launch of improved products is fostering the Dermatology diagnostic devices and therapeutics market growth
Innovation of new and improved products is driving growth of the market. For example, new product Dupixent approved by the U.S. FDA in 2017, is an injectable medication for the adult patients with moderate or acute eczema. This is mainly for the patients affected by the disease which cannot be controlled with prescription therapies used on skin (topically). Some of the major players operating in the global dermatology diagnostic devices and therapeutics market include Agfa-Gevaert N.V., Valeant Pharmaceuticals International, Inc., Cutera, Inc., Astellas Pharma, Inc., Galderma S.A., Novartis International AG., Dino-Lite Europe/IDCP B.V., Genentech, LEO Pharma A/S, Michelson Diagnostics Ltd, and Sun Pharmaceutical Industries Ltd.
Purchase This Premium Report To Access Full Information @ https://www.coherentmarketinsights.com/insight/buy-now/933
Table of Content
Global Dermatology Diagnostic Devices and Therapeutics Market Research Report
Section 1: Global Dermatology Diagnostic Devices and Therapeutics Industry Overview
Section 2: Global Economic Impact on Dermatology Diagnostic Devices and Therapeutics Industry
Section 3: Global Market Competition by Industry Producers
Section 4: Global Productions, Revenue (Value), according to Regions
Section 5: Global Supplies (Production), Consumption, Export, Import, geographically
Section 6: Global Productions, Revenue (Value), Price Trend, Product Type
Section 7: Global Market Analysis, on the basis of Application
Section 8: Dermatology Diagnostic Devices and Therapeutics Market Pricing Analysis
Section 9: Market Chain, Sourcing Strategy and Downstream Buyers
Section 10: Strategies and key policies by Distributors/Suppliers/Traders
Section 11: Key Marketing Strategy Analysis, by Market Vendors
Section 12: Market Effect Factors Analysis
Section 13: Global Dermatology Diagnostic Devices and Therapeutics Market Forecast
Other Reports
U.S. 503B Compounding Pharmacies Market
U.S. Injectable Compounding Pharmacy Market
About Us:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
